Published in Neurology on August 01, 1993
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci (2010) 1.44
Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry (1995) 1.37
Brain and spinal cord MRI in motor neuron disease. J Neurol Neurosurg Psychiatry (1996) 1.32
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging (2011) 1.11
Eyelid "apraxia" in patients with motor neuron disease. J Neurol Neurosurg Psychiatry (1995) 0.93
Motor neuron disease and frontotemporal dementia: One, two, or three diseases? Ann Indian Acad Neurol (2010) 0.79
Imaging in motor neuron disease. Neurology (1994) 0.75
Structural and functional changes in patients with motor neuron disease. J Neurol Neurosurg Psychiatry (1996) 0.75
Imaging in motor neuron disease. Neurology (1994) 0.75
CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol (1998) 2.45
Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke (1998) 2.34
Amnestic people with Alzheimer's disease who remembered the Kobe earthquake. Br J Psychiatry (1998) 2.26
Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol (1994) 2.18
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol (1998) 2.00
Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci (2001) 1.72
Transient global amnesia: clinical characteristics and prognosis. Neurology (1987) 1.72
Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett (2000) 1.65
Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab (1998) 1.64
Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med (1998) 1.55
IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J Neuroimmunol (1999) 1.50
A case of anorexia nervosa with acute renal failure resulting from rhabdomyolysis. Acta Neurol Scand (1990) 1.48
Three-dimensional ultrasonographic evaluation of ovarian tumours: a preliminary study. Hum Reprod (1999) 1.47
Asymmetric cortical degenerative syndromes: clinical and radiologic correlations. Neurology (1992) 1.47
Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol (1996) 1.46
Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke (2000) 1.42
Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by noninvasive tissue oximetry. Neurology (1997) 1.42
Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron (2001) 1.41
CD16 antigen density on neutrophils in chronic myeloproliferative disorders. Am J Clin Pathol (1997) 1.39
A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score. Neuroradiology (2000) 1.33
The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol (1988) 1.31
Antiinflammatory principles of Atractylodes rhizomes. Chem Pharm Bull (Tokyo) (1979) 1.29
C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res (1997) 1.25
Retinocochleocerebral vasculopathy. Medicine (Baltimore) (1998) 1.23
Antiinflammatory principles of Aconitum roots. J Pharmacobiodyn (1980) 1.23
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest (1999) 1.21
Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg (1988) 1.20
Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol (2000) 1.20
A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells. Mol Cell Biol (1992) 1.20
Repetitive involuntary movement associated with episodic cerebral ischemia. Ann Neurol (1985) 1.20
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry (2000) 1.19
Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology (2001) 1.19
Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry (1997) 1.17
Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology (1996) 1.15
Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology (1986) 1.14
Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry (1997) 1.14
Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry (2002) 1.13
The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis. Clin Immunol Immunopathol (1997) 1.12
Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost (1995) 1.11
Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology (1998) 1.10
Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol (1998) 1.09
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology (1998) 1.09
Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol (1998) 1.08
Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol (1998) 1.08
Degradation of ribulose-bisphosphate carboxylase by vacuolar enzymes of senescing French bean leaves: immunocytochemical and ultrastructural observations. Protoplasma (2001) 1.08
[Pharmacological studies on 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) as an anti-inflammatory agent]. Nihon Yakurigaku Zasshi (1967) 1.07
A case with a 120 base pair insertional mutation in the prion protein gene: the first case in Japan. J Neurol Neurosurg Psychiatry (2005) 1.07
Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience (1997) 1.07
Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron (1995) 1.07
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett (1997) 1.06
Experience with Arnold-Chiari malformation, 1960 to 1970. J Neurosurg (1976) 1.06
Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand (1996) 1.06
A progressive neurologic disorder with supranuclear vertical gaze paresis and distinctive bone marrow cells. Mayo Clin Proc (1984) 1.05
Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur J Neurosci (2001) 1.05
Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull (Tokyo) (1990) 1.03
Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem Biophys Res Commun (1992) 1.03
Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J Cereb Blood Flow Metab (1998) 1.03
Amygdalar volume and emotional memory in Alzheimer's disease. Am J Psychiatry (1999) 1.02
Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol (1995) 1.02
A role for CD9 molecules in T cell activation. J Exp Med (1996) 1.00
The effect of crude drugs on experimental hypercholesteremia: mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull (Tokyo) (1988) 1.00
Multifocal eosinophilic granuloma presenting as progressive brainstem and cerebellar dysfunction. J Neurol Neurosurg Psychiatry (1994) 0.99
Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci (1997) 0.99
Immunohistochemical investigation of cerebral ischemia in gerbils. J Neuropathol Exp Neurol (1985) 0.99
Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport (1999) 0.99
Three-dimensional ultrasonographic assessment of fetal hands and feet. Ultrasound Obstet Gynecol (1998) 0.98
Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology (1999) 0.98
Incidence of cluster headaches: a population-based study in Olmsted County, Minnesota. Neurology (1994) 0.98
Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants. Kidney Int Suppl (1997) 0.97
Neoplastic epithelial cells express alpha-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravis. FEBS Lett (1991) 0.96
Immunohistochemical investigation of ischemic and postischemic damage after bilateral carotid occlusion in gerbils. Stroke (1988) 0.95
Antiinflammatory principles of Caesalpinia sappan wood and of Haematoxylon campechianum wood. Planta Med (1977) 0.95
Impact of emotion on memory. Controlled study of the influence of emotionally charged material on declarative memory in Alzheimer's disease. Br J Psychiatry (2000) 0.95
Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology (1985) 0.95
Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection. Cytokine (2006) 0.94
Fatigue in patients with Parkinson's disease. Behav Neurol (2000) 0.94
Immunohistochemical localization of creatine kinase BB-isoenzyme in human brain: comparison with tubulin and astroprotein. Brain Res (1983) 0.94
Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission. Neurology (1987) 0.94
A novel variant of transthyretin (Tyr114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem Biophys Res Commun (1990) 0.93
Reversible ataxia following chronic exposure to paradichlorobenzene. J Neurol Neurosurg Psychiatry (1988) 0.93
Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology (1998) 0.93
[Biologically active principles of crude drugs. Antidiabetic principles of corni fructus in experimental diabetes induced by streptozotocin (author's transl)]. Yakugaku Zasshi (1981) 0.93
Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 0.93
Immunohistochemical investigation of cerebral ischemia during recirculation. J Neurosurg (1985) 0.93
Eyelid "apraxia" in patients with motor neuron disease. J Neurol Neurosurg Psychiatry (1995) 0.93